Related Experiment Video
Updated: May 30, 2026
05:18
Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
Published on: January 16, 2026
Current trends in implantable left ventricular assist devices.
Jens Garbade1, Hartmuth B Bittner, Markus J Barten
1Department of Cardiac Surgery, Leipzig Heart Center, University of Leipzig, Struempellstraße 39, 04289 Leipzig, Germany.
Cardiology Research and Practice
|August 9, 2011
Summary
Left ventricular assist devices (LVADs) offer improved outcomes for end-stage heart failure patients, evolving into a viable destination therapy. This review details current LVADs, their use, and patient selection for mechanical circulatory support.
Area of Science:
- Cardiology
- Biomedical Engineering
- Transplantation Medicine
Background:
- Shortage of donor organs for heart transplantation necessitates alternative strategies.
- Left ventricular assist devices (LVADs) have shown improved applicability and durability for end-stage heart failure.
- Mechanical circulatory support is increasingly recognized as a viable treatment option.
Purpose of the Study:
- To review currently available types of left ventricular assist devices (LVADs).
- To discuss the clinical use and outcomes associated with LVADs.
- To focus on the patient selection process for LVAD implantation.
Main Methods:
- Review of current literature on left ventricular assist devices (LVADs).
- Analysis of outcomes data from studies on continuous flow and pulsatile LVADs.
- Examination of patient selection criteria for mechanical circulatory support.
Main Results:
- Left ventricular assist devices (LVADs) have evolved, with newer pumps offering improved outcomes for destination therapy.
- Continuous flow pumps demonstrate significant evolution in outcomes post-REMATCH trial.
- Second-generation pulsatile LVADs also show promising results in managing heart failure.
Conclusions:
- Left ventricular assist devices (LVADs) represent a critical advancement in managing end-stage heart failure.
- Patient selection is paramount for optimizing outcomes with mechanical circulatory support.
- LVADs are increasingly established as a durable treatment option, including destination therapy.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:24Cardiac Catheterization III: Left Heart Catheterization
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...